Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-14 Sale | 2024-08-16 4:07 pm | Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director | 8,846 | $3.6895 | $32,637 | 46,069 (Direct) | View |
| 2024-02-02 Sale | 2024-02-05 7:55 pm | Arbutus Biopharma Corp | ABUS | Sims Karen Chief Medical Officer | 4,358 | $2.3125 | $10,078 | 529,442 (Direct) | View |
| 2024-02-02 Sale | 2024-02-05 7:54 pm | Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer | 9,593 | $2.3125 | $22,184 | 631,907 (Direct) | View |
| 2024-02-02 Sale | 2024-02-05 7:54 pm | Arbutus Biopharma Corp | ABUS | Sofia Michael J. Chief Scientific Officer | 9,982 | $2.3125 | $23,083 | 2,090,083 (Indirect Direct) | View |
| 2024-02-02 Sale | 2024-02-05 7:54 pm | Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Interim President & CEO | 10,164 | $2.3125 | $23,504 | 1,999,893 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-14 Exercise | 2024-08-16 4:07 pm | N/A 2024-11-13 | Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director | 54,915 | $0 | 46,069 (Direct) | View |
| 2024-08-14 Exercise | 2024-08-16 4:07 pm | N/A N/A | Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director | 54,915 | $0.56 | 46,069 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:17 pm | 2024-05-23 2034-05-23 | Arbutus Biopharma Corp | ABUS | BURGESS DANIEL D Director | 67,000 | $0 | 67,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:16 pm | 2024-05-23 2034-05-23 | Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director | 67,000 | $0 | 67,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:14 pm | 2024-05-23 2034-05-23 | Arbutus Biopharma Corp | ABUS | HENRIQUES RICHARD C JR Director | 67,000 | $0 | 67,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:12 pm | 2024-05-23 2034-05-23 | Arbutus Biopharma Corp | ABUS | Meyers James R Director | 67,000 | $0 | 67,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:10 pm | 2024-05-23 2034-05-23 | Arbutus Biopharma Corp | ABUS | Rewolinski Melissa Director | 67,000 | $0 | 67,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:07 pm | 2024-05-23 2034-05-23 | Arbutus Biopharma Corp | ABUS | Torti Frank Director | 67,000 | $0 | 67,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:55 pm | N/A 2034-02-01 | Arbutus Biopharma Corp | ABUS | Naftzger J. Christopher General Counsel and CCO | 475,600 | $0 | 475,600 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:55 pm | N/A 2034-02-01 | Arbutus Biopharma Corp | ABUS | Sims Karen Chief Medical Officer | 504,900 | $0 | 529,442 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:54 pm | N/A 2034-02-01 | Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer | 562,500 | $0 | 631,907 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:54 pm | N/A 2034-02-01 | Arbutus Biopharma Corp | ABUS | Sofia Michael J. Chief Scientific Officer | 547,300 | $0 | 2,090,083 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:54 pm | N/A 2034-02-01 | Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Interim President & CEO | 618,900 | $0 | 1,999,893 (Direct) | View |
| 2023-07-12 Option Award | 2023-07-13 4:13 pm | N/A 2033-07-12 | Arbutus Biopharma Corp | ABUS | Rewolinski Melissa Director | 110,000 | $0 | 110,000 (Direct) | View |
| 2023-07-10 Option Award | 2023-07-12 4:50 pm | N/A 2033-07-10 | Arbutus Biopharma Corp | ABUS | Sims Karen Chief Medical Officer | 153,640 | $0 | 153,640 (Direct) | View |
Ownership | 2023-07-12 4:48 pm | N/A N/A | Arbutus Biopharma Corp | ABUS | Sims Karen Chief Medical Officer | 0 | $0 | 317,460 (Direct) | View |
| 2023-07-10 Option Award | 2023-07-12 4:12 pm | N/A 2033-07-10 | Arbutus Biopharma Corp | ABUS | Naftzger J. Christopher General Counsel and CCO | 500,000 | $0 | 500,000 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-26 4:27 pm | 2023-05-24 2033-05-24 | Arbutus Biopharma Corp | ABUS | HENRIQUES RICHARD C JR Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-26 4:22 pm | 2023-05-24 2033-05-24 | Arbutus Biopharma Corp | ABUS | BURGESS DANIEL D Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-26 4:18 pm | 2023-05-24 2033-05-24 | Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-26 4:12 pm | 2023-05-24 2033-05-24 | Arbutus Biopharma Corp | ABUS | Torti Frank Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-26 4:06 pm | 2023-05-24 2033-05-24 | Arbutus Biopharma Corp | ABUS | Meyers James R Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 4:12 pm | N/A 2033-02-01 | Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Chief Business Officer | 418,400 | $0 | 1,725,857 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 4:11 pm | N/A 2033-02-01 | Arbutus Biopharma Corp | ABUS | Sofia Michael J. Chief Scientific Officer | 410,900 | $0 | 1,881,465 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 4:11 pm | N/A 2033-02-01 | Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer | 395,000 | $0 | 395,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 4:10 pm | N/A 2033-02-01 | Arbutus Biopharma Corp | ABUS | Collier William H. President and CEO | 1,082,500 | $0 | 1,082,500 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 4:10 pm | N/A 2033-02-01 | Arbutus Biopharma Corp | ABUS | Howard Elizabeth EVP, GC, Compliance | 348,400 | $0 | 364,724 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 4:19 pm | 2022-05-25 2032-05-25 | Arbutus Biopharma Corp | ABUS | HENRIQUES RICHARD C JR Director | 41,000 | $0 | 41,000 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 4:17 pm | 2022-05-25 2032-05-25 | Arbutus Biopharma Corp | ABUS | BURGESS DANIEL D Director | 41,000 | $0 | 41,000 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 4:16 pm | 2022-05-25 2032-05-25 | Arbutus Biopharma Corp | ABUS | Meyers James R Director | 41,000 | $0 | 41,000 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 4:15 pm | 2022-05-25 2032-05-25 | Arbutus Biopharma Corp | ABUS | Torti Frank Director | 41,000 | $0 | 41,000 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 4:13 pm | 2022-05-25 2032-05-25 | Arbutus Biopharma Corp | ABUS | Tran Tram Director | 41,000 | $0 | 41,000 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 4:10 pm | 2022-05-25 2032-05-25 | Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director | 41,000 | $0 | 41,000 (Direct) | View |
| 2022-01-20 Option Award | 2022-01-20 5:55 pm | N/A 2032-01-20 | Arbutus Biopharma Corp | ABUS | Collier William H. President and CEO | 787,550 | $2.81 | 787,550 (Direct) | View |
| 2022-01-20 Option Award | 2022-01-20 5:55 pm | N/A 2032-01-20 | Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer | 285,000 | $2.81 | 285,000 (Direct) | View |
| 2022-01-20 Option Award | 2022-01-20 5:54 pm | N/A 2032-01-20 | Arbutus Biopharma Corp | ABUS | Howard Elizabeth Chief Compliance Officer | 237,500 | $2.81 | 237,500 (Direct) | View |
| 2022-01-20 Option Award | 2022-01-20 5:54 pm | N/A 2032-01-20 | Arbutus Biopharma Corp | ABUS | Sofia Michael J. Chief Scientific Officer | 285,000 | $2.81 | 285,000 (Direct) | View |
| 2022-01-20 Option Award | 2022-01-20 5:54 pm | N/A 2032-01-20 | Arbutus Biopharma Corp | ABUS | Picchio Gaston Chief Development Officer | 256,500 | $2.81 | 256,500 (Direct) | View |
| 2022-01-20 Option Award | 2022-01-20 5:53 pm | N/A 2032-01-20 | Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Chief Business Officer | 325,850 | $2.81 | 325,850 (Direct) | View |